Resilience to Present at the 42nd Annual J.P. Morgan Healthcare Conference
SAN DIEGO, CA, January 4, 2024 – National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening access...
NEWS
Read on
Resilience Announces Expansion in West Chester
Project will create 440 new jobs and include further development of Resilience’s West Chester biomanufacturing site
Resilience Appoints Bill Marth as President of Services
National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, today...
BridgeBio and Resilience Announce Strategic Multi-Year Partnership
Resilience to manufacture BridgeBio’s lead investigational gene therapy treatments, BBP-631 and BBP-812 Partnership provides an innovative, capital...
Resilience Announces Joint Venture with Lifera in Saudi Arabia
The joint venture with Lifera would build an advanced large-scale, commercial drug product manufacturing facility in Riyadh, Saudi Arabia Resilience...
Resilience Approved For $410M Financing From The Department Of Defense, In Partnership With The Development Finance Corporation, To Establish Resilient Biomanufacturing Capacity
Financing focused on domestic biomanufacturing capacity and capabilities for biologics, vaccines, and nucleic acids
